Literature DB >> 20501776

Esophageal adenocarcinoma incidence: are we reaching the peak?

Heiko Pohl1, Brenda Sirovich, H Gilbert Welch.   

Abstract

BACKGROUND: A steep increase in the incidence of esophageal adenocarcinoma has been observed between 1973 and 2001, but recent trends have not been reported. Our aim was to examine recent trends in esophageal adenocarcinoma incidence.
METHODS: We used the Surveillance Epidemiology and End Results database of the National Cancer Institute to identify all patients who were diagnosed with esophageal adenocarcinoma between 1973 and 2006. Incidence trends were analyzed for esophageal adenocarcinoma overall and by stage using joinpoint regression.
RESULTS: Overall esophageal adenocarcinoma incidence increased from 3.6 per million in 1973 to 25.6 per million in 2006. Incidence trend analysis, however, suggests that the increase has slowed, from an 8.2% annual increase prior to 1996 to 1.3% increase in subsequent years (P = 0.03). Stage-specific trend analyses suggest that the change in overall esophageal adenocarcinoma incidence largely reflects a plateau in the incidence of early stage disease. Its slope has changed direction, from a 10% annual increase prior to 1999 to a 1.6% decline in subsequent years (P = 0.01).
CONCLUSIONS: The incidence of early stage esophageal adenocarcinoma seems to have plateaued. IMPACT: Although definitive conclusions will require additional years of data, the plateau in early stage disease might portend stabilization in the overall incidence of esophageal adenocarcinoma. Copyright 2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20501776     DOI: 10.1158/1055-9965.EPI-10-0012

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  148 in total

1.  The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.

Authors:  Rom S Leidner; Lakshmeswari Ravi; Patrick Leahy; Yanwen Chen; Beth Bednarchik; Mirte Streppel; Marcia Canto; Jean S Wang; Anirban Maitra; Joseph Willis; Sanford D Markowitz; Jill Barnholtz-Sloan; Mark D Adams; Amitabh Chak; Kishore Guda
Journal:  Genes Chromosomes Cancer       Date:  2012-02-03       Impact factor: 5.006

Review 2.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

3.  Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies.

Authors:  Helen Moinova; Rom S Leidner; Lakshmeswari Ravi; James Lutterbaugh; Jill S Barnholtz-Sloan; Yanwen Chen; Amitabh Chak; Sanford D Markowitz; Joseph E Willis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-07       Impact factor: 4.254

4.  Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway.

Authors:  Qiuyang Zhang; Chunhua Yu; Sui Peng; Hao Xu; Ellen Wright; Xi Zhang; Xiaofang Huo; Edaire Cheng; Thai H Pham; Kiyotaka Asanuma; Kimmo J Hatanpaa; Davood Rezai; David H Wang; Venetia Sarode; Shelby Melton; Robert M Genta; Stuart J Spechler; Rhonda F Souza
Journal:  Gastroenterology       Date:  2013-10-09       Impact factor: 22.682

5.  In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.

Authors:  Sui Peng; Xiaofang Huo; Davood Rezaei; Qiuyang Zhang; Xi Zhang; Chunhua Yu; Kiyotaka Asanuma; Edaire Cheng; Thai H Pham; David H Wang; Minhu Chen; Rhonda F Souza; Stuart Jon Spechler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

Review 6.  Microbiome in reflux disorders and esophageal adenocarcinoma.

Authors:  Liying Yang; Noami Chaudhary; Jonathan Baghdadi; Zhiheng Pei
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

7.  Feasibility of a simplified narrow-band imaging classification system for Barrett's esophagus for novice endoscopists.

Authors:  Hiroto Furuhashi; Kenichi Goda; Yuichi Shimizu; Masayuki Kato; Masakazu Takahashi; Akira Dobashi; Koji Hirata; Ayane Oba; Taku Shigesawa; Masaki Inoue; Hiroaki Matsui; Chika Kinoshita; Yoshitaka Ando; Masahiro Ikegami; Tadakazu Shimoda; Mototsugu Kato
Journal:  J Gastroenterol       Date:  2019-01-02       Impact factor: 7.527

Review 8.  Barrett oesophagus in 2013: risk stratification and surveillance in Barrett oesophagus.

Authors:  Emmanuel C Gorospe; Kenneth K Wang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-12-10       Impact factor: 46.802

9.  DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.

Authors:  Muhammad A Alvi; Xinxue Liu; Maria O'Donovan; Richard Newton; Lorenz Wernisch; Nicholas B Shannon; Kareem Shariff; Massimiliano di Pietro; Jacques J G H M Bergman; Krish Ragunath; Rebecca C Fitzgerald
Journal:  Clin Cancer Res       Date:  2012-12-14       Impact factor: 12.531

10.  Is Sleeve Gastrectomy Always an Absolute Contraindication in Patients with Barrett's?

Authors:  Michel Gagner
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.